We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUSK icon
11951
Mammoth Energy Services
TUSK
$160M
$41K ﹤0.01%
+18,972
New +$42.5K
VGZ icon
11952
CALL
Vista Gold
VGZ
$337M
$41K ﹤0.01%
+60,100
New +$51K
VSTM icon
11953
PUT
Verastem
VSTM
$596M
$41K ﹤0.01%
2,975
+433
+17% +$6.9K
VLD
11954
CALL
DELISTED
Velo3D, Inc.
VLD
$41K ﹤0.01%
854
-1,140
-57% -$133K
ASXC
11955
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$41K ﹤0.01%
104,200
-2,600
-2% -$1.16K
GENE
11956
DELISTED
Genetic Technologies Ltd.
GENE
$41K ﹤0.01%
7,223
+4,831
+202% +$34.9K
VCSA
11957
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$41K ﹤0.01%
709
+192
+37% +$20.2K
VNTR
11958
CALL
DELISTED
Venator Materials PLC
VNTR
$41K ﹤0.01%
+19,700
New +$40.3K
ALZN icon
11959
CALL
Alzamend Neuro
ALZN
$7.43M
$40K ﹤0.01%
34
-5
-13% -$6.48K
CARM
11960
PUT
DELISTED
Carisma Therapeutics
CARM
$40K ﹤0.01%
2,475
-1,305
-35% -$14.9K
GNFT
11961
DELISTED
Genfit
GNFT
$40K ﹤0.01%
+12,533
New +$45.2K
IMMP
11962
PUT
Immutep
IMMP
$56M
$40K ﹤0.01%
19,700
-7,600
-28% -$18.8K
PZG icon
11963
Paramount Gold Nevada
PZG
$132M
$40K ﹤0.01%
89,481
+70,179
+364% +$38.6K
REKR icon
11964
PUT
Rekor Systems
REKR
$98.2M
$40K ﹤0.01%
23,000
-30,700
-57% -$87.6K
TBLA icon
11965
PUT
Taboola.com
TBLA
$1.09B
$40K ﹤0.01%
16,000
-8,700
-35% -$31.9K
TROO icon
11966
PUT
TROOPS Inc
TROO
$243M
$40K ﹤0.01%
18,700
+100
+0.5% +$300
XOS icon
11967
PUT
Xos
XOS
$29.9M
$40K ﹤0.01%
727
-73
-9% -$5.83K
YTEN
11968
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$40K ﹤0.01%
+745
New +$52.6K
AMPE
11969
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$40K ﹤0.01%
791
+96
+14% +$7.14K
SRGA
11970
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$40K ﹤0.01%
11,631
+2,443
+27% +$13.5K
ASTLW icon
11971
Algoma Steel Group Warrant
ASTLW
$155K
$39K ﹤0.01%
19,119
-500
-3% -$1.24K
BMRA icon
11972
Biomerica
BMRA
$4.88M
$39K ﹤0.01%
1,682
-2,419
-59% -$69.1K
CRDL
11973
CALL
Cardiol Therapeutics
CRDL
$207M
$39K ﹤0.01%
29,500
+4,200
+17% +$5.98K
IRON icon
11974
CALL
Disc Medicine
IRON
$3.03B
$39K ﹤0.01%
760
+110
+17% +$4.87K
CYPH
11975
PUT
Cypherpunk Technologies Inc
CYPH
$69.4M
$39K ﹤0.01%
3,420
+1,860
+119% +$24.1K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.